Defining the future of brain health
The only technology for accessible and evidence-based measurements of the brain.
Experience it yourselfThe core principles behind our products
Actionable
Leveraging advanced algorithms to drive improvements in brain health and develop new interventions.
Offer Kernel Scans at your clinic →Science-backed
We lead with robust science and engage with leaders in the community.
Read our publications →Differentiated
A deep technology platform that both scales and breaks through the limitations of those that came before.
Learn more about the technology →From brain data to insight
Kernel delivers detailed information about brain function by combining our non-invasive brain measurements with algorithmic advances. You can now reliably track the performance of your brain.
- Book a scan with one of our partner clinics
- Get scanned in 30 minutes or less
- Review your results with our user-friendly reports
- Consult with your health team and see how interventions change your brain health
Follow your brain function over time
Unlike genetics, our brains are constantly changing and regular measurement is important to understand what factors create the biggest changes in function.
Kernel's longitudinal reports let you visualize your cognitive health so you and your clinician can track these changes, measure progress, and optimize interventions.
Built for wellness and medicine
Discover our industry-leading tracer wellness products and learn more about our upcoming marer medical products.
Brain Agetracer
We track our step count and sleep quality, now you can track your brain health. Brain Age is an objective measure of health built from thousands of scans.
Book a scan with one of our clinics →Cognitiontracer
The only cognitive tracker designed to assess healthy brains. Receive a detailed composition report of key cognitive domains and see how your cognitive performance stacks up to others.
Book a scan with one of our clinics →Depressionmarer
Our depression study investigates whether brain activity can help predict if patients will respond to TMS and Spravato® (esketamine) treatments. Early results suggest Kernel Flow may offer new insights for selecting the right treatment for the right patient at the right time.
Learn more about our ongoing work →Cognitionmarer
In a published study, Kernel Flow successfully detected early patterns of brain activity associated with mild cognitive impairment (MCI). This result highlights the platform's potential to support early identification of cognitive decline in clinical settings. Additional studies are being planned to assess more detailed profiles of cognitive performance in the context of disease diagnostics.
Read our recent publication →Research Opportunities
Want to participate in a paid research study that helps our team develop the next generation of brain health tools?
Visit KerneLabs to learn more →
